Search results for: 'heart rhythm disorders i'

This research service is a monthly innovation tracker for Asia Pacific. The objective of this research service is to help the reader foresee the direction of industry change by knowing about the latest trends in the market. For each innovative idea, Frost & Sullivan has expressed its opinion, explaining the novelty of the idea , the value out of th...

Frost & Sullivan organized the 13th edition of its flagship Intelligent Mobility Summit 2021 on July 14 and 15, 2021. The focus of the two-day virtual summit was “Intelligent Mobility: Innovating to Zero” with the spotlight on the Asia-Pacific region. This year, the Summit brought together a stellar group of industry thought leaders, policymakers, ...

Mitochondria are vital structures in the human body, and they play an active role in several processes. They are widely recognized as the powerhouses of the cell because of their essential function in energy production. In addition, mitochondria have a significant impact on several functions of the human body; as a result, any dysfunction in mitoch...

12 Sep 2018  |  North America  |  Market Research

Global Automotive Cybersecurity Market, Forecast to 2025

By 2025, 68.0% of Market Investments Will be Raised from Technology Providers, Semiconductor Companies and Tier-I Suppliers

Infographics

×

Key Issues Addressed

This study analyses the strategies, competitive landscape, business models, and future focus areas of OEMs, tier-I suppliers, and security start-up companies in the automotive cybersecurity market. Increasing vehicle connectivity has given rise to the risks of potential cyber-attacks in the industry. This has drastically increased customer awarene...

22 Aug 2024  |  Global  |  Technology Research

Pipeline Assessment for Cardiovascular Diseases

Advanced Drug Modalities Fuel Cardiovascular Therapeutics Future Growth Potential

Infographics

×

Globally, CVD is the leading cause of death, with resurgence in higher-income countries and higher prevalence in low- and middle-income countries. While there have been many advancements made to this indication using wearables and advanced diagnostics and devices, growth in therapeutics has been veiled. Traditional pharmacotherapy faces the drawbac...

28 Aug 2020  |  Global  |  Technology Research

Data Science Impacting the Pharmaceutical Industry

Part I: Drug Discovery Applications

Infographics

×

Data science and AI have the potential to transform drug discovery in terms of costs, speed and efficiency. With explosion in biomedical data, data sharing and analysis platforms have surged. AI technologies are moving to the next phase of advancements, and when combined with other emerging tech areas, AI is expected to witness a full fledged adopt...

08 Apr 2021  |  South Asia, Middle East & North Africa  |  Market Research

Transformative Mega Trends in the Indian Solar Inverters Market

Future Growth Potential Enhanced by Rooftop Inverter Opportunities and C&I Segment Contribution

Infographics

×

Key Issues Addressed

India is a signatory to the Paris climate change agreement, which requires at least 40% of its energy to be from renewable sources by 2030. By 2022, India targets 175GW from renewable sources, out of which it plans to achieve 100GW from solar sources with rooftop solar contributing about 40GW. The Ministry of Renewable Energy has launched a number...

This study analyzes the emergence of engineered antibody therapeutics for cancer, examining the factors driving their adoption. The limitations of monoclonal antibodies have led to an increasing demand for novel formats. Companies are developing multispecific antibodies, such as bispecifics and trispecifics, and antibody fragments, such as Fab and ...

30 Sep 2015  |  North America  |  Market Research

Analysis of the Cardiac Biomarker Diagnostics Market

Emerging Biomarkers Disrupt and Spur Growth in the Heart Failure Segment

Infographics

×

The cardiac biomarker diagnostics market is a niche but upcoming space in the United States. With regulations favoring personalized medicine and diagnostics, large companies are focusing their investment in researching and detecting new biomarkers to differentiate their products in this competitive market. In addition to growing prevalence rates th...